These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27785736)

  • 1. Relationship between Adverse Gastric Reactions and the Timing of Enteric-Coated Aspirin Administration.
    Guo W; Lu W; Xu Y; Wang L; Wei Q; Zhao Q
    Clin Drug Investig; 2017 Feb; 37(2):187-193. PubMed ID: 27785736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions.
    Dammann HG; Burkhardt F; Wolf N
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1109-14. PubMed ID: 10468689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of gastric ulcers caused by plain aspirin or nonsteroidal antiinflammatory agents in patients treated with a combination of cimetidine, antacids, and enteric-coated aspirin.
    Jaszewski R; Calzada R; Dhar R
    Dig Dis Sci; 1989 Sep; 34(9):1361-4. PubMed ID: 2766902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of gastric injury with enteric- versus nonenteric-coated aspirin.
    Banoob DW; McCloskey WW; Webster W
    Ann Pharmacother; 2002 Jan; 36(1):163-6. PubMed ID: 11816246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB; Fort JG; Zhang Y
    Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment.
    Morris AD; Holt SD; Silvoso GR; Hewitt J; Tatum W; Grandione J; Butt JH; Ivey KJ
    Scand J Gastroenterol Suppl; 1981; 67():131-5. PubMed ID: 6941392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.
    Kelly JP; Kaufman DW; Jurgelon JM; Sheehan J; Koff RS; Shapiro S
    Lancet; 1996 Nov; 348(9039):1413-6. PubMed ID: 8937281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study.
    Chowdhury A; Ganguly G; Chowdhury D; Santra A; Gupta JD; Roy T
    Indian J Gastroenterol; 2001; 20(6):227-9. PubMed ID: 11817775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy.
    Silvoso GR; Ivey KJ; Butt JH; Lockard OO; Holt SD; Sisk C; Baskin WN; Mackercher PA; Hewett J
    Ann Intern Med; 1979 Oct; 91(4):517-20. PubMed ID: 314764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in gastric mucosal hemorrhage and ulceration with chronic high-level dosing of enteric-coated aspirin granules two and four times a day.
    Lanza FL; Rack MF; Wagner GS; Balm TK
    Dig Dis Sci; 1985 Jun; 30(6):509-12. PubMed ID: 3873326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.
    Hawthorne AB; Mahida YR; Cole AT; Hawkey CJ
    Br J Clin Pharmacol; 1991 Jul; 32(1):77-83. PubMed ID: 1888645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
    Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP
    Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.
    Whellan DJ; Goldstein JL; Cryer BL; Eisen GM; Lanas A; Miller AB; Scheiman JM; Fort JG; Zhang Y; O'Connor C
    Am Heart J; 2014 Oct; 168(4):495-502.e4. PubMed ID: 25262259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formulation versus regular formulation in healthy volunteers.
    Blondon H; Barbier JP; Mahé I; Deverly A; Kolsky H; Bergmann JF
    Fundam Clin Pharmacol; 2000; 14(2):155-7. PubMed ID: 10796063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric retention of enteric-coated aspirin tablets in beagle dogs.
    Nap RC; Breen DJ; Lam TJ; De Bruyne JJ
    J Vet Pharmacol Ther; 1990 Jun; 13(2):148-53. PubMed ID: 2384905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
    Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
    J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or nonsteroidal antiinflammatory drug therapy.
    Jaszewski R
    J Clin Gastroenterol; 1990 Feb; 12(1):10-3. PubMed ID: 2303676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is enteric aspirin safer than regular aspirin?
    Johns Hopkins Med Lett Health After 50; 2013 Aug; 25(7):7. PubMed ID: 24386685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.